Abstract:Background: Bisphenol A (BPA) and, with increasing occurrence, its analogs bisphenol S (BPS) and bisphenol F (BPF) are applied in many consumer products, leading to humans being exposed from a vast number of sources and via several routes. Estrogenic and anti-androgenic effects are exerted by the chemical BPA, and also by its analogs. Therefore, realistic exposure assessments are needed for assessing risks related to cumulative exposure. Objectives: Biomonitoring for BPA, BPS, and BPF was conducted in a human study embedded in the EU project EuroMix and the measured urinary concentrations were compared to source-to-dose calculations for source allocation and plausibility test of the model. Methods: For two 24-hour study periods separated by 2-3 weeks, 144 adult volunteers in Norway kept detailed diaries on food consumption, personal care product (PCP) use, and thermal paper (TP) handling. Concurrently, 24 h urine was collected and urinary levels of BPA, BPS, and BPF were analyzed using ultra-high performance liquid chromatography and tandem mass spectrometry (UPLC-MS-MS). In line with the information obtained from the first study day, bisphenol exposure from food, PCPs, TP, and dust was modeled primarily individual-based with probabilistic models. Estimates for BP excretion over 24 h were obtained with the models and compared to measured amounts. Results: Modeled aggregate internal exposures covered the full range of measured urinary amounts for all BP analogs. In general, individual-based medians of modeled BPA exposures were in good agreement with the measurements, but individual-specific correlation was lacking. Modeled exposures mostly underestimated BPS and BPF levels in participants with positive measurements (53% and 8%), except for the P95 values of modeled BPS exposure that were higher than measured amounts if TP was handled. Most likely, diet and TP were the sources contributing the most to BP exposure in this study. Urinary measurements did not reveal a significant correlation between the amounts of canned food consumed, the number of PCPs used, or the number of TP handling events and levels of BPA, BPS, or BPF. Conclusions: The good agreement between the ranges of modeled BPA exposure and measured BPA amounts indicates that available concentrations, especially from the main exposure source food, mirror the exposure situation realistically, and suggests that the exposure model considers the relevant exposure sources. The lack of individual-specific correlations means that the individual measured amounts and modeled exposures did not vary in parallel, e.g. due to mismatch of BP concentrations in food, TP, and other sources, or delayed internal exposure. The underestimation of modeled BPS and BPF exposure suggests that not all relevant sources were included in the respective exposure models. This could be due to a lack of input data, e.g. for food items, or due to an increased replacement of BPA with structural analogs compared to the used concentration and occurrence data.

Deriving in Vivo Bioconcentration Factors of a Mixture of Fragrance Ingredients Using a Single Dietary Exposure and Internal Benchmarking.

Bioconcentration of Cedarwood Oil Constituents in Rainbow Trout.

Concentration dependence of in vitro biotransformation rates of hydrophobic organic sunscreen agents in rainbow trout S9 fractions: Implications for bioaccumulation assessment

A Benchmarking Method to Measure Dietary Absorption Efficiency of Chemicals by Fish.

Several Current-Use, Non-Pbde Brominated Flame Retardants Are Highly Bioaccumulative: Evidence from Field Determined Bioaccumulation Factors.

METHODS FOR ESTIMATING THE BIOCONCENTRATION FACTOR OF IONIZABLE ORGANIC CHEMICALS

Improved measurements of partition coefficients for polybrominated diphenyl ethers.

Approach for extrapolating in vitro metabolism data to refine bioconcentration factor estimates

Determining high-quality critical body residues for multiple species and chemicals by applying improved experimental design and data interpretation concepts

Dosing Methods to Enable Cell-Based In Vitro Testing of Complex Substances: A Case Study with a PAH Mixture

Investigating the bioaccumulation potential of anionic organic compounds using a permanent rainbow trout liver cell line

The EuroMix human biomonitoring study: Source-to-dose modeling of cumulative and aggregate exposure for the bisphenols BPA, BPS, and BPF and comparison with measured urinary levels

Relationships Between the Bioavailability of Polybrominated Diphenyl Ethers in Soils Measured with Female C57BL/6 Mice and the Bioaccessibility Determined Using Five in Vitro Methods

Metabolomic and Transcriptomic Analysis of MCF-7 Cells Exposed to 23 Chemicals at Human-Relevant Levels: Estimation of Individual Chemical Contribution to Effects

Integrating the lifelong exposure dimension of a chemical mixture into the risk assessment process. Application to trace elements

Quantitative Estimation of Relative Contributions of Direct and Indirect Exposures to Perfluorooctane Sulfonate in Organisms Using the Isomer Profiling Technique

Benchmarking of BMDC assay and related QSAR study for identifying sensitizing chemicals

Physiologically based pharmacokinetic (PBPK) modeling of BDE-209 following oral exposure in Chinese population

Using HPLC Retention Parameters to Estimate Fish Bioconcentration Factors of Organic Compounds

Evaluation of the Oral Bioaccessibility of Legacy and Emerging Brominated Flame Retardants in Indoor Dust

Are Human Exposure Assessment the Same for Non-Persistent Organic Chemicals? -from the Lens of Urinary Variability and Predictability.